Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:46 pm Sale | 2025-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Octagon Capital Advisors LP | 9,067,500 3.300% | -1,382,500 (-13.23%) | Filing History |
| 2025-11-14 4:18 pm Purchase | 2025-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA Capital Management, L.P. | 27,662,481 9.900% | 2,316,493 (+9.14%) | Filing History |
| 2025-08-14 6:11 pm Purchase | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA Capital Management, L.P. | 25,345,988 9.900% | 3,806,523 (+17.67%) | Filing History |
| 2025-08-14 08:10 am Purchase | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 25,183,287 9.900% | 4,509,980 (+21.82%) | Filing History |
| 2025-08-06 2:13 pm Sale | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | MORGAN STANLEY MS | 16,858,644 6.700% | -770,620 (-4.37%) | Filing History |
| 2025-08-06 12:14 pm Sale | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 15,627,822 6.200% | -737,842 (-4.51%) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 13,153,326 5.200% | -367,207 (-2.72%) | Filing History |
| 2025-07-03 12:23 pm Purchase | 2025-06-26 | 13G | Taysha Gene Therapies, Inc. TSHA | GOLDMAN SACHS GROUP INC GS | 12,748,968 5.100% | 12,748,968 (New Position) | Filing History |
| 2025-06-03 9:54 pm Purchase | 2025-05-30 | 13D | Taysha Gene Therapies, Inc. TSHA | Paul B Manning | 25,601,111 9.800% | 2,124,778 (+9.05%) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 20,673,307 9.990% | 8,304,973 (+67.15%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 12,368,334 5.900% | -6,137,222 (-33.16%) | Filing History |
| 2025-02-12 09:22 am Sale | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 16,365,664 8.000% | -2,312,862 (-12.38%) | Filing History |
| 2025-02-05 6:05 pm Purchase | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | Octagon Capital Advisors LP | 10,450,000 5.100% | 10,450,000 (New Position) | Filing History |
| 2025-02-05 10:43 am Purchase | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | MORGAN STANLEY MS | 17,629,264 8.600% | 17,629,264 (New Position) | Filing History |
| 2024-11-14 5:51 pm Sale | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III, L.P. | 9,000,000 4.400% | -1,412,872 (-13.57%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA Capital Management, L.P. | 21,539,465 9.990% | 2,869,376 (+15.37%) | Filing History |
| 2024-11-14 09:40 am Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Avoro Capital Advisors LLC | 23,094,444 9.990% | 23,094,444 (New Position) | Filing History |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 18,678,526 9.113% | -3,760,598 (-16.76%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 13,520,533 6.600% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 13,520,533 6.600% | 12,474,043 (+1191.99%) | Filing History |